Morphogenesis, Inc. and CohBar, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy

The companies hosted a joint webcast on May 23, 2023, to discuss the transaction.

CohBar Website

Get In Touch With Us


10500 University Center Drive
Suite 110
Tampa, FL 33612


Tel: (813) 875-6600

By clicking "submit" below, you accept Morphogenesis, Inc.’s Terms of Use and acknowledge its Privacy Policy applies.

This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.